Effects of ketamine and magnesium on morphine induced tolerance and dependence in mice

Daru

Volumn 13, Issue 3, 2005, Pages 110-115

  Asl, Bohlul Habibi ^a   Hassanzadeh, Kambiz ^a   Moosazadeh, Saber ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ketamine; Magnesium; Morphine; Tolerance; Withdrawal

Indexed keywords

KETAMINE; MAGNESIUM; MORPHINE; NALOXONE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERANCE; EVALUATION; HOT PLATE TEST; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; STATISTICAL SIGNIFICANCE; WITHDRAWAL SYNDROME;

EID: 31544455009     PISSN: 15608115     EISSN: 15608115     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nestler EJ, Aghajanian GK.Molecular and cellular basis of addiction. Science 1997; 278: 58-63.
2. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995; 62: 259-274.
3. Liu JG, Anand KJ. Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain research review 2000; 38: 1-19.
4. Hamdy MM, Noda Y, Miyazaki M, Mamiya T, Nozaki A, Nitta A, Sayed M, Assi AA, Gomaa A, Nabeshima T. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade. Behav Brain Res. 2004; 152: 263-270.
5. Rang HP, Dale MM, Ritter JM. Pharmacology, Drug dependence and drug abuse 1999: 470-482.
6. Mercadante S, Arcuri E, Tirelli W, Casuccio A. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage. 2000; 20: 246-251.
7. Christensen D, Idanpaan-Heikkila JJ, Guilbaud G, Kayser V. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy. Br J Pharmacol. 1998 ; 125: 1641-1650.
8. Elliott K, Kest B, Man A, Kao B, Inturrisi CE. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development. Neuropsychopharmacology. 1995; 13: 347-356.
9. Shio LC, Chang CC, Chih SW, Chin CW, Paolo T. Study the effect and mechanism of dextromethorphan on preventing the development of morphine tolerance and dependence in rats. J Med Sci 2002; 22: 171-176.
10. Tokuyama S, Wakabayashi H, Ho IK. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur J Pharmacol. 1996; 295: 123-9.
11. Keith A, Trujillo. Are NMDA receptors involved in opiate-induced neural and behavioral plastisity?Psychoparmacology 2000; 151: 121-141.
12. Bisaga A, Popik P. In search of a new pharmacological treatment for drug and alcohol addiction: Nmethyl-D-aspartate (NMDA) antagonists. Drug Alcohol Depend. 2000; 59: 1-15.
13. Gutstein HB, Trujillo KA. MK-801 inhibits the development of morphine tolerance at spinal sites. Brain Res. 1993; 626: 332-334.
14. Holthusen H, Backhaus P, Boeminghaus F, Breulmann M, Lipfert P. Preemptive analgesia: no relevant advantage of preoperative compared with postoperative intravenous administration of morphine, ketamine, and clonidine in patients undergoing transperitoneal tumor nephrectomy. Reg Anesth Pain Med. 2002; 27: 249-53.
15. Suzuki M, Tsueda K, Lansing PS, Tolan MM, Fuhrman TM, Ignacio CI, Sheppard RA. Small-dose ketamine enhances morphine-induced analgesia after outpatient surgery. Anesth Analg. 1999; 89: 98-103.
16. Bertrand S, Cazalets JR. Regulation by glycine, Mg2+ and polyamines of the N-methyl-D-aspartate-induced locomotion in the neonatal rat spinal cord in vitro. Neuroscience. 1999; 94: 1199-1206.
17. Begon S, Pickering G, Eschalier A, Dubray C. Magnesium increases morphine analgesic effect in different experimental models of pain. Anesthesiology. 2002; 96: 627-632.
18. Hollmann MW, Liu HT, Hoenemann CW, Liu WH, Durieux ME. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics. Anesth Analg. 2001; 92: 1173-1181.
19. Zarauza R, Saez-Fernandez AN, Iribarren MJ, Carrascosa F, Adame M, Fidalgo I, Monedero P. A comparative study with oral nifedipine, intravenous nimodipine, and magnesium sulfate in postoperative analgesia. Anesth Analg. 2000; 91: 938-943.
20. Fallon JH, and Loughlin SE. Substantia nigra. In: The Rat Nervous System, edited by Paxinos G. Orlando, FL: Academic, 1995; 215-237.
21. Mereu G, Costa E, Armstrong DM, and Vicini S. Glutamate receptor subtypes mediated excitatory synaptic currents of dopamine neurons in midbrain slices. J Neurosci.1991;11: 1359-1366 .
22. Shen Z, and Johnson SW. A slow excitatory postsynaptic current mediated by G protein-coupled metabotropic glutamate receptors in rat ventral tegmental dopamine neurons. Eur J Neurosci. 1997; 9: 48-54.
23. Gariano RF, and Groves PM. Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices. Brain Res.1988; 462: 194-198.
24. Murase S, Grenhoff J, Chouvet G, Gonon FG, and Svensson TH. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett. 1993; 157: 53-56.
25. Sevensson TH and Tung CS. Local cooling of pre-frontal cortex induces pacemaker -like firing of dopamine neurons in rat ventral tegmental area in vivo.Acta Phisiol Scand.1989; 136:135-136.